ReviewBiomedicines2021

Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment.

Tomoyuki Makino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.